Search research articles
Contact Us
Filters
Showing results (111-120 of 497) with videos related to
Page
of 50
Sort By:
Drugs in R&D
|
August 13, 2017
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
Paolo Grassi, Elena Verzoni, Raffaele Ratta, et al.
Melanoma Research
|
December 7, 2018
Pembrolizumab in the treatment of advanced/metastatic melanoma: a single-center institution experience
Carolina Cimminiello, Alice Indini, Lorenza Di Guardo, et al.
Oncology
|
November 8, 2014
Time from nephrectomy as a prognostic factor in metastatic renal cell carcinoma patients receiving targeted therapies: overall results from a large cohort of patients
Giuseppe Procopio, Isabella Testa, Elena Verzoni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
Adjuvant surgery after carboplatin and VP16 in resectable small cell lung cancer
Giulia Veronesi, Paolo Scanagatta, Francesco Leo, et al.
Oncotarget
|
April 9, 2016
How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies
Sara Pusceddu, Filippo De Braud, Giuseppe Lo Russo, et al.
Cancer Treatment Reviews
|
July 16, 2013
Emerging toxicities in the treatment of non-small cell lung cancer: ocular disorders
Francesco Agustoni, Marco Platania, Milena Vitali, et al.
International Journal of Cancer
|
January 8, 2019
Panitumumab-based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trials
Dominik Paul Modest, Fernando Rivera, Jean-Baptiste Bachet, et al.
Critical Reviews in Oncology/Hematology
|
July 31, 2007
Dendritic cell sarcoma: an analytic overview of the literature and presentation of original five cases
Tommaso De Pas, Gianluca Spitaleri, Giancarlo Pruneri, et al.
Journal of the National Cancer Institute
|
August 31, 2007
Re: Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial
Nicola Fazio, Roberto Biffi, Giuseppe Curigliano, et al.
International Journal of Cancer
|
December 10, 2019
A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer
Carolina Reduzzi, Marta Vismara, Marco Silvestri, et al.
Page
of 50
Search research articles
Search
Showing results (111-120 of 497) with videos related to
Sort By:
Page
of 50
Drugs in R&D
|
August 13, 2017
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
Paolo Grassi, Elena Verzoni, Raffaele Ratta, et al.
Melanoma Research
|
December 7, 2018
Pembrolizumab in the treatment of advanced/metastatic melanoma: a single-center institution experience
Carolina Cimminiello, Alice Indini, Lorenza Di Guardo, et al.
Oncology
|
November 8, 2014
Time from nephrectomy as a prognostic factor in metastatic renal cell carcinoma patients receiving targeted therapies: overall results from a large cohort of patients
Giuseppe Procopio, Isabella Testa, Elena Verzoni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
Adjuvant surgery after carboplatin and VP16 in resectable small cell lung cancer
Giulia Veronesi, Paolo Scanagatta, Francesco Leo, et al.
Oncotarget
|
April 9, 2016
How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies
Sara Pusceddu, Filippo De Braud, Giuseppe Lo Russo, et al.
Cancer Treatment Reviews
|
July 16, 2013
Emerging toxicities in the treatment of non-small cell lung cancer: ocular disorders
Francesco Agustoni, Marco Platania, Milena Vitali, et al.
International Journal of Cancer
|
January 8, 2019
Panitumumab-based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trials
Dominik Paul Modest, Fernando Rivera, Jean-Baptiste Bachet, et al.
Critical Reviews in Oncology/Hematology
|
July 31, 2007
Dendritic cell sarcoma: an analytic overview of the literature and presentation of original five cases
Tommaso De Pas, Gianluca Spitaleri, Giancarlo Pruneri, et al.
Journal of the National Cancer Institute
|
August 31, 2007
Re: Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial
Nicola Fazio, Roberto Biffi, Giuseppe Curigliano, et al.
International Journal of Cancer
|
December 10, 2019
A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer
Carolina Reduzzi, Marta Vismara, Marco Silvestri, et al.
Page
of 50